Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natriuretic Peptides in Chronic Heart Failure
Hans‐Peter Brunner‐La Rocca, Sandra Sanders-van Wijk
Cardiac failure review (2019) Vol. 5, Iss. 1, pp. 44-49
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers
Alexander Е. Berezin, Alexander A. Berezin
Disease Markers (2020) Vol. 2020, pp. 1-21
Open Access | Times Cited: 108
REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA -Related Dilated Cardiomyopathy
Pablo García‐Pavía, José F. Rodríguez‐Palomares, Gianfranco Sinagra, et al.
Circulation Heart Failure (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 9
Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications
Daniela Maria Tănase, Smaranda Radu, Sinziana Al Shurbaji, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2629-2629
Open Access | Times Cited: 63
Biomarkers in Heart Failure with Preserved Ejection Fraction
Antoni Bayés‐Genís, Germán Cediel, Mar Domingo, et al.
Cardiac failure review (2022) Vol. 8
Open Access | Times Cited: 34
The role of non-invasive devices for the telemonitoring of heart failure patients
Alessandro Faragli, Dawud Abawi, Caroline Quinn, et al.
Heart Failure Reviews (2020) Vol. 26, Iss. 5, pp. 1063-1080
Open Access | Times Cited: 46
Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics
Speranza Rubattu, Massimo Volpe
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 3991-3991
Open Access | Times Cited: 43
Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N‐terminal pro‐B‐type natriuretic peptide and high‐sensitivity troponin T
Alberto Aimo, James L. Januzzi, Giuseppe Vergaro, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 11, pp. 2078-2088
Open Access | Times Cited: 39
NT-proBNP for Risk Prediction in Heart Failure
Giuseppe Vergaro, Francesco Gentile, Laura M.G. Meems, et al.
JACC Heart Failure (2021) Vol. 9, Iss. 9, pp. 653-663
Open Access | Times Cited: 39
Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure
Giuseppe Vergaro, Francesco Gentile, Alberto Aimo, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 4, pp. 2084-2095
Open Access | Times Cited: 27
Racial differences in diuretic therapy, B-type natriuretic peptide values, and prognosis in acute heart failure
Yu Horiuchi, Yuya Matsue, Nicholas Wettersten, et al.
Journal of Cardiology (2025)
Closed Access
Non-Invasive Hemodynamic Assessment of Heart Failure With Preserved Ejection Fraction
Sabina Istrătoaie, Charlotte Frost, Erwan Donal
Korean Circulation Journal (2025) Vol. 55, Iss. 3, pp. 165-165
Closed Access
Chronic heart failure with preserved ejection fraction: current understanding of the problem
О. А. Пономарева, Vladimir E. Vladimirskiy, I.V. Petukhova
Perm Medical Journal (2025) Vol. 42, Iss. 1, pp. 12-19
Open Access
Role of novel biomarkers in diabetic cardiomyopathy
Marko Kumrić, Tina Tičinović Kurir, Josip A. Borovac, et al.
World Journal of Diabetes (2021) Vol. 12, Iss. 6, pp. 685-705
Open Access | Times Cited: 31
Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology
Brenda Moura, Alberto Aimo, Abdallah Al‐Mohammad, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 10, pp. 1577-1596
Open Access | Times Cited: 31
Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring heart failure
Francesca G. Bellagambi, C. Petersen, Pietro Salvo, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Diagnosis and Management of Heart Failure
Inna P. Gladysheva, Ryan D. Sullivan
MDPI eBooks (2022)
Open Access | Times Cited: 21
Detection of NT-proBNP Using Optical Fiber Back-Reflection Plasmonic Biosensors
Ana Sofia Assunção, M. A. Vidal, Maria João Martins, et al.
Biosensors (2024) Vol. 14, Iss. 4, pp. 173-173
Open Access | Times Cited: 3
How to diagnose heart failure with preserved ejection fraction
Sabina Istrătoaie, Luna Gargani, Bogdan A Popescu, et al.
European Heart Journal - Cardiovascular Imaging (2024) Vol. 25, Iss. 11, pp. 1505-1516
Closed Access | Times Cited: 3
Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review
Michiel T.H.M. Henkens, Sharon Remmelzwaal, Emma Robinson, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 9, pp. 1586-1597
Open Access | Times Cited: 22
Differential Role of Circulating microRNAs to Track Progression and Pre-Symptomatic Stage of Chronic Heart Failure: A Pilot Study
Yuri D’Alessandra, Mattia Chiesa, Maria Cristina Carena, et al.
Biomedicines (2020) Vol. 8, Iss. 12, pp. 597-597
Open Access | Times Cited: 22
Whole blood transcriptomic profiling identifies molecular pathways related to cardiovascular mortality in heart failure
Mintu Nath, Simon P.R. Romaine, Andrea Koekemoer, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 6, pp. 1009-1019
Open Access | Times Cited: 13
Non-invasive assessment of HFpEF in mouse models: current gaps and future directions
María Villalba‐Orero, Pablo García‐Pavía, Enrique Lara‐Pezzi
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 13
N‐terminal pro‐B‐type natriuretic peptide post‐discharge monitoring in the management of patients with heart failure and preserved ejection fraction – a randomized trial: The NICE study
Domingo A. Pascual‐Figal, Álvaro Hernández Vicente, Francisco J. Pastor‐Pérez, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 4, pp. 776-784
Open Access | Times Cited: 2
Epidemiology of Asymptomatic Pre-heart Failure: a Systematic Review
Aurore Bergamasco, Anouk Déruaz‐Luyet, Nicholas D. Gollop, et al.
Current Heart Failure Reports (2022) Vol. 19, Iss. 3, pp. 146-156
Open Access | Times Cited: 12
Biomarkers in heart failure: a focus on natriuretic peptides
Mohamed M. Eltayeb, Iain Squire, Shirley Sze
Heart (2023) Vol. 110, Iss. 11, pp. 809-818
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top